DAY 1 • Sunday, 9 February 2020
• Room: National A & B (Main Hall) •
| 07:00am - 6:00pm | REGISTRATION | |
| 7:30am - 12:30pm | WORKSHOP Hands-on MpMRI interpretation and MRI-TRUS fusion focal targeted therapy teaching course Chairs: Rajan Gupta (USA), Ardeshir Rastinehad (USA), Arvin George (USA) Room:National A & B (Main Hall)
|
|
| 7:30am - 8:10am | Segment 1: MRI Interpretation MRI Course Director: Ardeshir Rastinehad (USA) MRI Course Instructors: Peter Choyke (USA), Ismail Baris Turkbey (USA), Bradford Wood (USA), Peter Pinto (USA), John Feller (USA), Arnauld Villers (France), Rajan Gupta (USA) > Introduction - Ardeshir Rastinehad (USA) > MRI Structured Reporting - Ardeshir Rastinehad (USA) > MRI Basics for a Urologist - Rajan Gupta (USA) > MRI Pitfalls - Ismail Baris Turkbey (USA) |
|
| 8:10am - 9:30am | Workshop (i). Lesion location via Structured Reporting Chairs: Peter Choyke (USA), John Feller (USA) (ii). Identify Lesions, Mark ROI of Lesion, Segment Prostate Instructors: Peter Pinto (USA), Rajan Gupta (USA), Ardeshir Rastinehad (USA), Arvin George (USA), Jochen Walz (France), Fernando Bianco (USA), Mark Emberton (United Kingdom), Andre Luis de Castro Abreu (USA) |
|
| 9:30am - 10:30am | Segment 2: Fusion targeting / Case Setup - Workflows Instructors: Arvin George (USA), Peter Pinto (USA), Ardeshir Rastinehad (USA), Osamu Ukimura (Japan), Andre Luis de Castro Abreu (USA), Fernando Bianco (USA), Mark Emberton (United Kingdom) |
|
| 10:30am - 10:45am | Coffee Break | |
| 10:45am - 12:30pm | Segment 3: Platforms and Performance of Focal Therapy - Talk with the Experts > HIFU - Mark Emberton (United Kingdom) > HIFU - Rafael Sanchez-Salas (France) > Cryoblation - Thomas Polascik (USA) > Irreversible Electroporation - Jean De La Rosette (Netherlands) > Photodynamic Therapy - Andre Luis de Castro Abreu (USA) > MRI guided laser ablation - John Feller (USA) Q and A |
|
| 12:30pm - 1:30pm | Lunch | |
| 1:30pm - 3:30pm | Workshop | Next Generation solution for today's prostate cancer Management (Click here to view further information) Room: East Room
|
|
| 1:30pm - 3:30pm | Prostate Consensus 1: Coming off active surveillance: Focal Therapy’s sweet spot? (closed session / by invitation only) Chairs: Thomas Polascik (USA) |
|
| Closed session - participation by invitation only | Room: Ashlawn North | |
| 1:30pm - 3:30pm | Prostate Consensus 2: Biomarkers in prostate focal therapy (closed session / by invitation only) Chairs: Rafael Sanchez Salas (France) |
|
| Closed session - participation by invitation only |
Room: Ashlawn South | |
| 1:30pm - 3:30pm | Poster session 1: Diagnostic / Imaging Moderator: Peter Choyke (USA) Room: Monticello East
|
|
| 1:30pm - 3:30pm | Poster session 2: Focal Therapies Room: Monticello West
|
|
| 3:30pm - 4:00pm | Coffee break | |
| 4:00pm - 5:45pm | Flagship Video Session: “This is how I do it” Room: National A & B (Main Hall)
Chairs: Arvin George (USA), Daniel Rukstalis (USA)1 "Trojan Horse" model for prostate cancer treatment using stromal vascular fraction (SVF) and oncolytic virus - John Feller (USA) 2 Robotic Approach to MRI-targeted + saturation biopsy - Kae Jack Tay (Singapore) 3 MRI Fusion Guided Prostate Partial Gland Cryoablation Aided by a Virtual 3D Modeling: A step by step illustration - Ezequiel Becher (USA) 4 Focal Cryoablation of the prostate - Osamu Ukimura (Japan) 5 Perineologic transperineal prostate biopsy - Mike Gorin (USA) 6 Epigenetics and mapping - TBD - Dave Crawford (USA) 7 Boiling histotripsy for FT - Vera Khokhlova (USA) (UW) 8 CEUS for evaluation and follow up of FT - Andre Luis de Castro Abreu (USA) 9 Cryoablation of renal masses and outcome in pT1b tumors - Jochen Walz (France) |
|
| 6:45pm - 7:00pm | Welcome & Networking Reception | |
DAY 2 • Monday, 10 February 2020
• Room: National A & B (Main Hall) •
| 7:00am - 8:00am | Industry Breakfast Symposium (Click here to view further information) |
| 8:00am - 8:45am | Epidemiology and Active Surveillance |
| Moderators: Peter Carroll (USA), Arnauld Villers (France) | |
| |
> Intelligent prostate cancer screening: Defining the need for precision diagnostics - Sigrid Carlsson (USA) > Is AS after FT the same as de novo AS? - Laurie Klotz (Canada) > Active Surveillance as an Alternative to Treatment for Small Renal Tumors - Phillip Pierorazio (USA) (JHH) Q&A |
| 8:45am - 9:45am | Patient Selection for Focal Therapy |
| Moderators: Daniel Rukstalis (USA), Georg Salomon (Germany), Kae Jack Tay (Singapore) | |
| > Focal therapy for intermediate-high risk prostate cancer: expanding indications - Andre Luis de Castro Abreu (USA) > Rationale for the high-risk primary patient - Mark Emberton (UK) > Rationale for salvage focal therapy - Aaron Katz (USA) > PT selection for renal ablation - Thomas Jarrett (USA) > Tissue-based genomic classifiers for prostate cancer: can they help identify candidates for AS or FT [Oncotype, Prolaris, Decipher] is there an impact on outcomes? - Peter Carroll (USA) Q&A |
|
| 9:45am - 10:15am | Debate presentations: Can focal therapy replace prostatectomy in men with a localized, clinically significant lesion and a negative standard biopsy? |
| Moderators: Herb Lepor, Andre Luis de Castro Abreu (USA), Laurie Klotz (Canada) Panelists: Mark Emberton (UK): PRO Peter Carroll (USA): CON |
|
| 10:15am - 10:45am |
Coffee break |
| 10:45am - 11:45am | Biopsy Panel |
| Moderator: Peter Ka-Fung Chiu (Hong Kong), David Crawford (USA), Soroush Rais-Bahrami (USA) > Patient Selection: How many bxs are minimally necessary vs too many? - Kae Jack Tay (Singapore) > A Negative Fusion Biopsy. What did I miss and what is the next step? - Peter Pinto (USA) > Renal Mass Biopsy: an underutilized technique. For whom and how? - Timothy McClure (USA) > Targeted biopsy for planning FT - Leonard Marks (USA) > Surveillance after FT: How to define success after focal therapy, MR targeted only vs MR Targeted and Standard Biopsy vs Imaging only - Herb Lepor (USA) Q&A |
|
| 11:45am - 12:15pm | Adjuncts and Immunotherapy as the holy grail |
| Chair: Phillip Pierorazio (USA), Rafael Sanchez Salas (France), Mark Emberton (United Kingdom) |
|
| Promise of Adjunct Immunotherapy - Kwanghee Kim (USA) Combinatorial strategies to optimize Freezing insult - John Baust (USA) |
|
| 12:15pm - 1:15pm | Industry Lunch Symposium (Click here to view further information) |
| 1:15pm - 1:30pm | How to start a focal therapy program for the General Urologist |
| Moderators: Fernando Bianco (USA), Leonard Marks (USA) > Screening, Staging and Follow up - Ardeshir Rastinehad (USA) > Focal Therapy Modality Selection, First Steps - Arvin George (USA |
|
| 1:30pm - 2:00pm | Imaging Panel 1: Engineering and Imaging News Panel |
| Moderators: Shyam Natarajan (USA), Kathy Nightingale (USA), Vera Khokhlova (USA) > Molecular Imaging to Aid in the Histologic Characterization of Small Renal Tumors - Mike Gorin (USA) > Computer Aided Detection of mpMRI - Anant Madabhushi (USA) [Case western] > Artificial Intelligence based margin prediction - Shyam Natarajan (USA) |
|
| 2:00pm - 2:40pm | Imaging Panel 2: Multiparametric MRI |
| Moderators: Rajan Gupta (USA), Peter Pinto (USA), Leonard Marks (USA) > PIRADS 3 - worthy of targeted biopsy or low yield? - Peter Choyke (USA) > mpMRI to detect recurrence - case presentations - Ismail Baris Turkbey (USA) > mpMRI - Is the next step to improve the technology or the community expert reader - Rajan Gupta Q&A |
|
| 2:40pm - 3:30pm | mpUS and High Frequency Ultrasound |
| Moderators: Christian Pavlovich (USA), Georg Salomon (Germany), Laurence Klotz (Canada) > Performance of micro-ultrasound imaging for diagnosis and treatment of PCa - David Crawford (USA) > Multi-parametric ultrasound for targeting prostate cancer procedures - Kathy Nightingale (USA) > Validating High frequency ultrasound with pathologic correlation - Jochen Walz (France) > Using high frequency US and targeted biopsy platforms for FT - Daniel Rukstalis (USA) > Proposed New End-point for Localized, Low-risk Prostate Cancer Trials: Progression-free and Radical Treatment-Free Survival – Inderbir Gill (USA) Q&A |
|
| 3:30pm - 4:00pm | Coffee break |
| 4:00pm - 4:40pm | Pathology, serum markers and genomic classifiers |
| Moderators: David Crawford (USA) > Prostate Consensus report 2020 - Thomas J. Polascik (USA), Wei Phin Tan (USA) > Serum and urine biomarkers for prostate cancer [PHI, 4k, SelectMDx]: where do they integrate with MRI - Timothy McClure (USA) > How the genetics of renal cancers impacts clinical behavior and treatment decisions - Marston Linehan (USA) - NCI > Interpreting prostate biopsies after focal therapy - Maria Merino (USA) Q&A |
|
| 4:40pm - 5:30pm | “From My Perspective” |
| Moderator: Herb Lepor (USA), Daniel Rukstalis (USA) > Why we need a Focal Therapy Society - Thomas Polascik (USA) > How to engage industry to partner with academics to impact the field - Jean de la Rosette (Netherlands) > Incorporating patient preference perspectives for novel PCa therapies - Charles Viviano (USA) |
DAY 3 • Tuesday, 11 February 2020
• Room: National A & B (Main Hall) •
| 7:15am - 7:30am | Consensus 1 & 2 - Presentation of consensus II results |
| Moderators: Thomas Polascik (USA), Pilar Laguna (Netherlands) |
|
| 7:30am - 9:45am | Trial updates: Latest prostate and kidney FT outcomes |
| PART I Moderators: Jochen Walz (France), Aaron Katz (USA), Kae Jack Tay (Singapore) > IRE Prostate - Jean De la Rosette (Netherlands) > Gold Nanoparticles Multi-Institutional Trial- NCT02680535 - Art Rastinehad (USA) > Boiling histotripsy for FT - Vera Khokhlova (USA) (UW) > Fusion guided VLL Microwave > Focal Radiotherapy - Soroush Rais-Bahrami (USA) > Focal Brachytherapy - Danny Song (USA) > Laser: Phase II outpatient MR-guided laser focal therapy: 10 yr interim results – John Feller (USA) > Laser: FLA out of bore - Shyam Natarajan (USA) > TACT study and MRI-guided Focal TULSA - Christian Pavlovich (USA) PART II Moderators: Jean De La Rosette (Netherlands), Ardeshir Rastinehad (USA) > Partial anterior prostatectomy- Arnauld Villers (France) > Prostate Cryoablation - 20 year experience TIPS and Tricks - Aaron Katz (USA) > HIFU – European experience update - Rafael Sanchez Salas (France) > Renal cryo - Pilar Laguna (Netherlands) > Renal IRE and RFA – Jeffrey Cadeddu (USA) > Radio-guided surgery - Georg Salomon (Germany) Q&A |
|
| 9:45am - 10:15am | Coffee break |
| 10:15am - 10:45am | Office-Based Procedures |
| Moderator: Osamu Ukimura (Japan), Peter Ka-Fung Chiu (Hong Kong) > Are we likely to acquire a code for fusion biopsy? - Norman Smith (USA) > What can be done/coded in the office? > Office Based MRI Fusion Targeted Prostate Cryoablation: 5 year outcomes with Tips and Tricks - Fernando Bianco (USA) Q&A |
|
| 10:45am - 11:15am | Focal Therapy Follow-up |
| Moderators: Jeffrey Cadeddu (USA), Peter Ka-Fung Chiu (Hong Kong) |
|
| > Surveillance after focal therapy of the prostate (Japan Consensus) - Amir Lebastchi (USA) > Defining radiologic success/failure after renal/prostate FT - Ismail Baris Turkbey (USA) > How reliable is MRI for follow-up? - Peter Pinto (USA) > How reliable is imaging vs biopsy after renal ablation and how to define success? - Bradford Wood (USA) |
|
| 11:15am - 12:30pm | Round table: “It didn’t work. Treatment of recurrence with Salvage therapy: which option?” |
| Moderator: Danny Song (USA), Fernando Bianco (USA), Arnauld Villers (France) > When is additional FT reasonable vs surgery? - Jeffrey Cadeddu (USA) > When is additional FT reasonable? - Osamu Ukimura (Japan) > Salvage surgical treatment after FT prostate failure - Rafael Sanchez Salas (France) |
|
| 12:30pm | Closing Ceremony |
| Closed session - participation by invitation only |
